Werewolf Therapeutics Inc (HOWL)
2.44
-0.07
(-2.79%)
USD |
NASDAQ |
Jun 28, 16:00
2.400
-0.04
(-1.64%)
After-Hours: 20:00
Werewolf Therapeutics Shareholders Equity (Quarterly): 117.59M for March 31, 2024
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | 117.59M |
December 31, 2023 | 111.37M |
September 30, 2023 | 112.44M |
June 30, 2023 | 118.60M |
March 31, 2023 | 121.07M |
December 31, 2022 | 122.34M |
September 30, 2022 | 130.95M |
Date | Value |
---|---|
June 30, 2022 | 129.84M |
March 31, 2022 | 139.32M |
December 31, 2021 | 152.79M |
September 30, 2021 | 169.30M |
June 30, 2021 | 181.56M |
March 31, 2021 | -153.75M |
December 31, 2020 | -51.86M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
-153.75M
Minimum
Mar 2021
181.56M
Maximum
Jun 2021
100.11M
Average
121.70M
Median
Shareholders Equity (Quarterly) Benchmarks
CEL-SCI Corp | 14.30M |
AIM ImmunoTech Inc | 4.826M |
IGC Pharma Inc | 7.321M |
NovaBay Pharmaceuticals Inc | 0.16M |
Protalix BioTherapeutics Inc | 29.79M |
Shareholders Equity (Quarterly) Related Metrics
Total Assets (Quarterly) | 177.60M |
Total Liabilities (Quarterly) | 60.01M |
Debt to Equity Ratio | 0.3352 |
Current Ratio | 6.707 |
Net Debt Paydown Yield | -2.81% |